Related Experiment Video

Updated: Jul 17, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

TAT-Bim induces extensive apoptosis in cancer cells

Hiroyuki Kashiwagi1, Jonathan E McDunn, Peter S Goedegebuure

  • 1Department of Surgery, Washington University School of Medicine, St. Louis, MO 63110, USA.

Annals of Surgical Oncology
|January 9, 2007
PubMed
Abstract

Insights

A novel peptide therapy, TAT-Bim, effectively induces apoptosis in cancer cells and enhances radiation treatment. This approach shows promise for improved cancer treatment strategies by targeting programmed cell death.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biotechnology

Background:

  • Apoptosis suppression is a hallmark of cancer development and contributes to treatment resistance.
  • Targeting apoptotic pathways is crucial for developing effective anti-cancer therapeutics.
  • Intracellular delivery of therapeutic agents is essential for targeting apoptosis in tumor cells.

Purpose of the Study:

  • To investigate the efficacy of a novel peptide construct, TAT-Bim, in inducing apoptosis in cancer cells.
  • To evaluate the synergistic effect of TAT-Bim with radiation therapy.
  • To assess the anti-tumor effects of TAT-Bim in preclinical cancer models.

Main Methods:

  • A peptide construct (TAT-Bim) was designed, combining a TAT transduction domain with a Bim BH3 domain.
  • Cancer cell lines (EL4, Panc-02, B16) were treated with TAT-Bim, with a non-functional mutant (TAT-Bim-inactive) as control.
  • In vivo studies involved intratumoral injection of TAT-Bim in murine cancer models to assess tumor growth and survival.

Main Results:

  • TAT-Bim was rapidly internalized by all tested cancer cell lines.
  • Dose-dependent induction of apoptosis was observed in cancer cells treated with TAT-Bim.
  • Sublethal irradiation enhanced TAT-Bim-induced apoptosis, and TAT-Bim significantly inhibited tumor growth in vivo.

Conclusions:

  • TAT-Bim represents a promising strategy for cancer therapy by antagonizing anti-apoptotic mechanisms.
  • Small peptide therapeutics like TAT-Bim can act as a 'second hit' when combined with conventional therapies.
  • This approach holds potential for driving tumor cells towards programmed cell death and improving treatment outcomes.

More Related Videos

Examining BCL-2 Family Function with Large Unilamellar Vesicles08:35

Examining BCL-2 Family Function with Large Unilamellar Vesicles

Published on: October 5, 2012

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...